In this study, the authors found that the cleaved TDP-43 (35-kDa fragment) mediated by caspase 3 was cytotoxic and promoted breast cancer cell apoptosis, which can serve as a therapeutic target to treat breast cancer (83). This evidence concerns the gene TARDBP and breast carcinoma.